Arcus Biosciences, Inc. (RCUS) Shareholders’ equity 2017–2025
Arcus Biosciences, Inc. (RCUS) shareholders’ equity at each fiscal year-end, per SEC filings.
$631.0MFY2025 · since FY2017: -$72.3M → $631.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $631.0M | +30.1% |
| FY2024 | $485.0M | +5.0% |
| FY2023 | $462.0M | -29.7% |
| FY2022 | $657.0M | -22.0% |
| FY2021 | $842.0M | +67.7% |
| FY2020 | $502.0M | +206.1% |
| FY2019 | $164.0M | -30.2% |
| FY2018 | $234.9M | +424.8% |
| FY2017 | -$72.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice